NF-κB activation by Helicobacter pylori requires Akt-mediated phosphorylation of p65 by Takeshima, Eriko et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
NF-κB activation by Helicobacter pylori requires Akt-mediated 
phosphorylation of p65
Eriko Takeshima1,2, Koh Tomimori1,2, Hirochika Kawakami1, 
Chie Ishikawa1,3,4, Shigeki Sawada1,5, Mariko Tomita1, Masachika Senba6, 
Fukunori Kinjo7, Hitomi Mimuro8, Chihiro Sasakawa8, Jiro Fujita2 and 
Naoki Mori*1
Address: 1Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, 
Okinawa 903-0215, Japan, 2Division of Control and Prevention of Infectious Diseases, Graduate School of Medicine, University of the Ryukyus, 
207 Uehara, Nishihara, Okinawa 903-0215, Japan, 3Division of Child Health and Welfare, Faculty of Medicine, University of the Ryukyus, 207 
Uehara, Nishihara, Okinawa 903-0215, Japan, 4The Japanese Society for the Promotion of Science (JSPS), Japan, 5Division of Oral and 
Maxillofacial Functional Rehabilitation, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan, 
6Department of Pathology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan, 7Department of 
Endoscopy, University Hospital, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan and 8Department of Microbiology 
and Immunology, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
Email: Eriko Takeshima - erichinai@yahoo.co.jp; Koh Tomimori - koh-tomi@future.ocn.ne.jp; 
Hirochika Kawakami - kawakami1975@yahoo.co.jp; Chie Ishikawa - chiezo@lab.u-ryukyu.ac.jp; Shigeki Sawada - k048707@eve.u-
ryukyu.ac.jp; Mariko Tomita - mtomita@med.u-ryukyu.ac.jp; Masachika Senba - mikiyo@net.nagasaki-u.ac.jp; 
Fukunori Kinjo - kinjofuk@med.u-ryukyu.ac.jp; Hitomi Mimuro - mim@ims.u-tokyo.ac.jp; Chihiro Sasakawa - sasakawa@ims.u-tokyo.ac.jp; 
Jiro Fujita - fujita@med.u-ryukyu.ac.jp; Naoki Mori* - n-mori@med.u-ryukyu.ac.jp
* Corresponding author    
Abstract
Background: The inflammatory response in Helicobacter pylori-infected gastric tissue is mediated
by  cag  pathogenicity island (PAI)-dependent activation of nuclear factor-κB (NF-κB).
Phosphatidylinositol 3-kinase (PI3K)/Akt signaling is known to play a role in NF-κB activation, but
little information is available on the relationship between H. pylori and PI3K/Akt signaling in gastric
epithelial cells. We examined whether H. pylori activates Akt in gastric epithelial cells, the role of
cag PAI in this process and the role of Akt in regulating H. pylori-induced NF-κB activation.
Results: Phosphorylated Akt was detected in epithelial cells of H. pylori-positive gastric tissues.
Although Akt was activated in MKN45 and AGS cells by coculture with cag PAI-positive H. pylori
strains, a cag  PAI-negative mutant showed no activation of Akt. H. pylori also induced p65
phosphorylation. PI3K inhibitor suppressed H. pylori-induced p65 phosphorylation and NF-κB
transactivation, as well as interleukin-8 expression. Furthermore, transfection with a dominant-
negative Akt inhibited H. pylori-induced NF-κB transactivation. Transfection with small interference
RNAs for p65 and Akt also inhibited H. pylori-induced interleukin-8 expression.
Conclusion: The results suggest that cag PAI-positive H. pylori activates Akt in gastric epithelial
cells and this may contribute to H. pylori-mediated NF-κB activation associated with mucosal
inflammation and carcinogenesis.
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Background
Helicobacter pylori causes various human gastric diseases.
In 10 to 20% of infected individuals, H. pylori-induced
chronic gastric inflammation progresses to gastroduode-
nal ulcers, gastric cancer or gastric mucosa-associated lym-
phoid tissue lymphoma [1,2]. Bacterial, environmental
and host genetic factors may affect the progress and out-
come of gastric disease in these individuals. Virulence of
individual H. pylori strains is one such factor responsible
for severe disease, and several virulence factors have been
described such as the presence of a cag  pathogenicity
island (PAI) and vacuolating cytotoxin (VacA) [3-6]. The
presence of cag  PAI genes correlates strongly with the
development of ulcer diseases and gastric cancer [7-9].
Nuclear factor-κB (NF-κB) is a crucial regulator of many
cellular processes, including immune response, inflam-
mation and apoptosis [10]. It has been established that
inflammation plays an important role in cancer develop-
ment [11]. The five known mammalian Rel genes encode
seven Rel-related proteins: RelA/p65; p105 and its
processing product, p50; p100 and its processing product,
p52; c-Rel; and RelB. Each contains an N-terminal Rel
homology domain that mediates DNA binding, dimeriza-
tion and interaction with the IκB family of NF-κB inhibi-
tors. p65, c-Rel and RelB contain C-terminal
transactivation domains, but p50 and p52 do not. The
prototypical NF-κB complex is a p50–p65 heterodimer. In
resting cells, NF-κB is complexed to cytoplasmic NF-κB
inhibitors. IκBα is the best characterized of these inhibi-
tors. NF-κB activation requires phosphorylation of two
conserved serine residues within the N-terminal domain
of IκBα (serines 32 and 36) [12]. Phosphorylation leads
to ubiquitination and 26S proteasome-mediated degrada-
tion of IκBα, thereby releasing NF-κB from the complex
where it translocates to the nucleus and activates various
genes. Stimulation such as cytokines results in the activa-
tion of specific intracellular signaling pathways with sub-
sequent activation of the IκB kinase (IKK) complex. This
complex comprises two catalytic subunits (IKKα and
IKKβ) and the regulatory subunit (IKKγ), and can phos-
phorylate IκBα [12]. Only H. pylori strains containing the
cag PAI (cag PAI+) can direct signaling in gastric epithelial
cells to activate the IKK complex and thus NF-κB, leading
to the release of chemoattractants such as interleukin (IL)-
8 [13]. However, the exact mechanism by which cag PAI+
H. pylori strains induce activation of NF-κB in gastric epi-
thelial cells is not clear yet. The cag PAI encodes a bacterial
type IV secretion capable of translocating effector mole-
cules [14]. Based on the observations that mutants of
CagA, the only type IV secretion system effector protein,
often induce a considerable amount of IL-8, early studies
reported that CagA did not activate NF-κB or IL-8 secre-
tion in infected cells [15,16]. However, CagA was recently
reported to induce IL-8 release through NF-κB activation
in time- and strain-dependent manners [17].
Protein kinases are also required for optimal NF-κB acti-
vation by targeting functional domains of NF-κB protein
itself. Phosphorylation of the p65 subunit plays a key role
in determining both the strength and duration of the NF-
κB-mediated transcriptional response [18,19]. Sites of
phosphorylation reported to date are serines 276 and 311,
in the Rel-homology domain, and serines 468, 529 and
536, three phosphoacceptor sites located in the transacti-
vation domain. Importantly, phosphorylation at serine
536 reduced the ability of p65 to bind IκBα [20] and facil-
itated the recruitment of TAFII31, a component of the
basal transcriptional machinery [21]. Phosphorylation at
serine 536 is also responsible for recruiting coactivators
such as p300 [22]. The above data emphasize the impor-
tance of p65 phosphorylation at serine 536 in the func-
tion of NF-κB. In contrast, p50 phosphorylation does not
regulate NF-κB activation, because p50 lacks a transactiva-
tion domain. Akt is a downstream effector of phosphati-
dylinositol 3-kinase (PI3K) that has been implicated in
phosphorylation of serine 536 on the p65 subunit
[18,19]. Akt activation also mediates multiple biological
activities including increased survival, proliferation and
growth of tumor cells. The present study investigated
whether Akt regulates NF-κB activation in response to H.
pylori infection.
Results
Immunohistochemical studies
H. pylori-positive gastritis biopsies of 10 patients were
immunostained for phosphorylated Akt. Staining was
limited to mucosal epithelial cells in all 10 patients (Fig-
ure 1A and Figure 1B), whereas no such staining was
observed in the normal mucosa of all three healthy volun-
teers (Figure 1C and Figure 1D). Epithelial cells from three
patients showed strong staining, while those of six
patients showed moderate staining, and the remainder
demonstrated weak staining.
Cag PAI is required for H. pylori-mediated IL-8 induction 
in gastric epithelial cells
The cag PAI is a 40-kbp cluster of approximately 27 genes
and encodes a type IV secretary apparatus which injects
the CagA protein, and possibly other unknown proteins,
into eukaryotic cells [14]. virD4 is one of seven genes in
cag PAI that are virulent (vir) gene homologues [23]. In H.
pylori, virD4 is thought to act as an adapter protein for the
transfer of CagA protein and possibly other yet unknown
proteins into the transfer channel formed by other Vir
proteins in cag PAI [24]. The virD4 mutant cannot translo-
cate CagA [24]. IL-8 cytokine is chemotactic for neu-
trophils and lymphocytes, and is induced in response toBMC Microbiology 2009, 9:36 http://www.biomedcentral.com/1471-2180/9/36
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H. pylori infection. Many of the cis-elements that regulate
IL-8 expression have been identified, including binding
sites for NF-κB [25]. H. pylori-induced IL-8 expression is
NF-κB dependent [26]. To examine the role of virulence
factors in H. pylori-mediated NF-κB activation, we com-
pared IL-8 induction in gastric epithelial cells infected
with Δcag PAI, ΔVacA, ΔvirD4 or wild-type H. pylori strain.
Infection with wild-type strain 26695 induced IL-8 mRNA
expression in MKN45 cells, while the isogenic mutant that
lacked  cag  PAI expression did not induce IL-8 mRNA
expression (Figure 2A). Wild-type H. pylori strain but not
Δcag PAI strain induced IL-8 mRNA expression in AGS
cells (Figure 2B). In contrast, VacA and virD4 null mutants
induced IL-8 mRNA expression similar to the parental
strain (Figure 2A). Our study on isogenic mutants derived
from the 26695 strain suggests that H. pylori cag PAI plays
an important role in the induction of IL-8 mRNA expres-
sion.
H. pylori activates Akt and induces phosphorylation of the 
NF- B p65 subunit in gastric epithelial cells
We next examined whether coculture of gastric epithelial
MKN45 cells with H. pylori results in activation of Akt,
using Western blot analysis. As shown in Figure 3A (rows
2 and 3), phosphorylated Akt levels increased after only
30 min of coculture and this phosphorylation persisted
for 3 h. There was no significant change in total Akt pro-
tein level in H. pylori-infected MKN45 cells (row 1). In
vitro Akt kinase activity also increased 30 min after the
addition of H. pylori to MKN45 cells (Figure 3A, bottom
row). Since Akt is an upstream kinase implicated in p65
phosphorylation [27], we then assessed p65 phosphoryla-
tion with an antibody specific for p65 phosphorylated on
serine 536. p65 phosphorylation was induced after 1 h of
stimulation with H. pylori (Figure 3A, row 5). H. pylori
infection also induced phosphorylated IκBα (Figure 3A,
row 7). Kinetic analysis of H. pylori-induced degradation
and resynthesis of IκBα in MKN45 cells revealed gradual
increase in IκBα levels (Figure 3A, row 6). These results
indicate that H. pylori-induced phosphorylation of IκBα
leads to proteasome-mediated degradation of IκBα,
thereby releasing NF-κB from the complex followed by its
translocation to the nucleus to activate genes. This signal
is terminated through cytoplasmic resequestration of NF-
κB, which depends on IκBα synthesis, a process requiring
NF-κB transcriptional activity [12]. Similar results were
obtained in AGS cells (Figure 3A).
We next examined whether the observed Akt activation
was specific to the cag PAI domain, based on the above
results indicating the importance of cag PAI expression for
IL-8 induction in gastric epithelial cells in vitro (Figure 2).
We used a wild-type H. pylori strain (26695) and an iso-
genic cag PAI mutant (Δcag PAI). Stimulation with the
wild-type strain induced Akt phosphorylation in MKN45
and AGS cells, while the isogenic mutant that lacked the
expression of cag PAI did not (Figure 3B). These results
suggest the important role of H. pylori cag PAI in the phos-
phorylation of Akt.
Phosphorylation of Akt in H. pylori-infected gastric mucosa Figure 1
Phosphorylation of Akt in H. pylori-infected gastric 
mucosa. Immunohistochemical detection of phosphorylated 
Akt in tissues of patients with H. pylori-positive gastritis. 
Serial sections of gastric biopsy specimens were stained with 
monoclonal antibody against phospho-Akt (serine 473). (A 
and B) Representative examples of mucosa from patients 
with H. pylori-positive gastritis. (C and D) Representative 
examples of normal mucosa. Note the positive staining for 
phospho-Akt in the mucosal epithelial cells of patients with 
H. pylori-positive gastritis. Original magnification, ×200.
cag PAI products of H. pylori are required for induction of IL- 8 mRNA expression Figure 2
cag PAI products of H. pylori are required for induc-
tion of IL-8 mRNA expression. Total RNA was extracted 
from MKN45 (A) or AGS cells (B) infected with the wild-
type strain 26695 (WT) or isogenic mutant ΔVacA, ΔvirD4 or 
Δcag PAI (Δcag) for the indicated times and used for RT-
PCR. Lane M contains markers. Representative results of 
three similar experiments.
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H. pylori-induced p65 phosphorylation is PI3K-dependent
Akt is a substrate for PI3K, and thus we investigated the
role of this kinase in H. pylori-induced Akt activation and
p65 phosphorylation. As expected, inhibition of PI3K
with LY294002 inhibited H. pylori-induced Akt activation
(Figure 4A, top row), but interestingly, also abrogated H.
pylori-induced p65 phosphorylation (Figure 4A, row 2).
Despite being mutually dependent, the nuclear transloca-
tion, DNA binding and transcriptional activity of NF-κB
may rely on independent regulatory elements. We investi-
gated the role of PI3K in each of these processes by using
the LY294002 inhibitor. MKN45 cells were infected with
H. pylori and NF-κB DNA binding was assessed by electro-
phoretic mobility shift assay (EMSA). As shown in Figure
4B, a complex was induced in these cells within 10 min
after infection with H. pylori. This binding activity was
reduced by the addition of either cold probe or a typical
NF-κB sequence derived from the CCL20 gene but not by
an oligonucleotide containing the AP-1 binding site (Fig-
ure 4C, lanes 2–4). Furthermore, an NF-κB DNA complex
composed of p50 and p65 was induced in MKN45 cells
within 10 min after infection with H. pylori, but pretreat-
ment of MKN45 cells with LY294002 did not inhibit H.
pylori-mediated NF-κB DNA binding activity (Figure 4B
and Figure 4C).
H. pylori-stimulated NF- B transcriptional activity is 
dependent on PI3K/Akt
Next, to assess whether H. pylori-induced PI3K activity
affected NF-κB transcriptional activity, we transfected
MKN45 cells with an NF-κB reporter construct (κB-LUC).
In contrast to the effect of LY294002 on the DNA-binding
activity of NF-κB, LY294002 pretreatment caused 65%
decline in H. pylori-stimulated luciferase expression from
κB-LUC (Figure 5A). Overexpression of the dominant-
negative Akt mutant also suppressed the ability of H. pylori
H. pylori activates Akt and induces p65 phosphorylation Figure 3
H. pylori activates Akt and induces p65 phosphorylation. (A) MKN45 or AGS cells were infected with H. pylori (ATCC 
49503) for the indicated times. Cells were harvested, lysed and subjected to immunoblotting with the indicated antibodies. Akt 
in vitro kinase assay was performed after immunoprecipitation of Akt, with GSK-3 fusion protein serving as the exogenous sub-
strate for Akt. Kinase reactions were analyzed by immunoblotting with monoclonal antibody for phospho-GSK-3 (serines 21 
and 9). (B) The cag PAI of H. pylori is required for induction of Akt phosphorylation. MKN45 or AGS cells were infected with 
either the wild-type H. pylori strain 26695 (WT) or its isogenic cag PAI-lacking mutant strain (Δcag) for 1 h. Cells were har-
vested, lysed and subjected to immunoblotting with the indicated antibodies. Representative results of three similar experi-
ments in each panel.
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to stimulate κB-LUC in a dose-dependent manner (Figure
5B). The above findings indicate that the transcriptional
activity but not the DNA binding activity of NF-κB is sen-
sitive to inhibition of Akt and PI3K.
PI3K inhibition or transfection with small interference 
RNAs for p65 and Akt suppresses H. pylori-induced IL-8 
expression
Finally, we investigated the effect of inhibition of H.
pylori-induced PI3K activity on IL-8 expression. Pretreat-
ment of MKN45 cells with LY294002 reduced H. pylori-
stimulated IL-8 mRNA expression as determined by
reverse transcription-polymerase chain reaction (RT-PCR)
(Figure 6A). Inhibition of PI3K also significantly
decreased the amount of IL-8 secreted by MKN45 cells
stimulated with H. pylori in a dose-dependent manner
(Figure 6B).
LY294002 is a chemical inhibitor, and thus its target spe-
cificity may be questionable. Thus, small interference
RNAs (siRNAs) for p65 and Akt were used to examine the
role of p65 and Akt activation in the signal transduction
pathway leading to IL-8 expression by H. pylori infection.
Each siRNA specifically inhibited the expression of p65
and Akt (Figure 7). Figure 7 also shows that H. pylori-
induced IL-8 mRNA expression was inhibited by siRNAs
for p65 and Akt, confirming that p65 and Akt are impor-
tant in H. pylori-induced IL-8 expression.
Discussion
NF-κB activation is known to regulate various cellular
responses, including apoptosis, and is required for the
induction of inflammatory and tissue-repair genes [10].
As reported previously [26,28], we demonstrated that H.
pylori  modulates the NF-κB system in gastric epithelial
cells by inducing IκBα phosphorylation and degradation,
NF-κB DNA binding activity, and NF-κB transcriptional
activity. Although this investigation was a preliminary in
nature in a small number of patients, we also showed that
H. pylori infection activated Akt in epithelial cells, both in
vivo and in vitro, and that this is dependent on an intact cag
PAI in vitro. Interestingly, H. pylori also stimulated endog-
enous p65 phosphorylation on serine 536. Phosphoryla-
tion of p65 at serine 536 in the transactivation domain
Involvement of PI3K in H. pylori-mediated Akt activation and  p65 phosphorylation Figure 4
Involvement of PI3K in H. pylori-mediated Akt acti-
vation and p65 phosphorylation. (A) MKN45 cells were 
pretreated for 60 min with LY294002 (20 μM) or medium 
alone, and infected with H. pylori (ATCC 49503) for the indi-
cated times (30–180 min). Cells were harvested, lysed and 
subjected to immunoblotting with the indicated antibodies. 
Akt in vitro kinase assays were performed as shown in Figure 
3A. (B) LY294002 had no effect on the H. pylori-stimulated 
DNA binding activity of NF-κB. MKN45 cells were pre-
treated for 60 min with LY294002 (20 μM) or medium alone, 
and infected with H. pylori (ATCC 49503) for the indicated 
times for EMSA (10–60 min). (C) H. pylori stimulated the for-
mation of a p65–p50 heterodimer in MKN45 cells infected 
with H. pylori (ATCC 49503) for 60 min. The cells were lysed 
and the competition and supershift assays were performed 
with the competitor oligonucleotides and the indicated anti-
bodies (Ab), respectively.
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an NF-κB-dependent promoter. MKN45 cells were cotrans-
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(Akt K179A/T308A/S473A). The cells were infected with H. 
pylori (ATCC 49503) 24 h later. Data are mean ± SD of three 
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enhances the transcriptional activity of NF-κB [19].
Although previous studies using pathogenic strains con-
taining the cag PAI showed NF-κB activation and cytokine
expression in gastric epithelial cells [13,28], ours is the
first demonstration that cag PAI+ H. pylori strains induce
gene expression through p65 phosphorylation, and that
H. pylori-induced p65 phosphorylation is PI3K/Akt-
dependent.
The role of PI3K/Akt signaling cascades in the regulation
of NF-κB transactivation remains controversial. The
present study agrees with previous investigators in dem-
onstrating that activation of PI3K/Akt promotes the acti-
vation of p65 [29], while some others found that
inhibition of the PI3K/Akt pathway augmented p65 acti-
vation [30]. We also analyzed how H. pylori-stimulated
PI3K activation leads to the activation of NF-κB, and iden-
tified a pathway initiated by the PI3K activation that is dis-
tinct from NF-κB DNA binding. In contrast to the lack of
effect of inhibition of PI3K on NF-κB DNA binding, pre-
treatment of MKN45 cells with LY294002 resulted in
marked inhibition of H. pylori-stimulated p65 phosphor-
ylation and the ability of H. pylori to activate NF-κB-
dependent transcription. Furthermore, a dominant-nega-
tive derivative of Akt blocked the ability of H. pylori to acti-
vate an NF-κB-dependent promoter. Therefore, the results
established a clear role of PI3K and its downstream effec-
tor Akt in modulating the transactivation potential of p65.
However, the kinases and signaling pathway responsible
for  H. pylori-induced p65 phosphorylation remain
unknown. Our data demonstrated for the first time that
PI3K and Akt participate in H. pylori-mediated NF-κB tran-
scriptional activity. Further studies are required to define
the exact signaling cascade involved in bacteria-induced
p65 phosphorylation and NF-κB activity.
Conclusion
Our data demonstrated the role of PI3K/Akt in H. pylori-
induced NF-κB transcriptional activity and subsequent IL-
8 production in gastric epithelial cells. We also demon-
strated an important role of PI3K/Akt in the regulation of
gastric responses to H. pylori infection, thereby elucidating
a novel mechanism that controls both transcription and
gene expression in bacterial pathogenesis.
Methods
Antibodies and reagents
Polyclonal antibodies to Akt, phospho-Akt (threonine
308), phospho-Akt (serine 473), p65 and phospho-p65
(serine 536), as well as monoclonal antibodies to phos-
pho-Akt (serine 473) and phospho-IκBα (serines 32 and
36) were purchased from Cell Signaling Technology (Bev-
erly, MA, USA). Polyclonal antibodies to IκBα and NF-κB
subunits p50, p65, c-Rel, p52 and RelB were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Monoclonal antibody to actin was purchased from Neo-
Markers (Fremont, CA, USA). PI3K inhibitor LY294002
was obtained from Calbiochem (La Jolla, CA, USA).
Bacterial strains
H. pylori ATCC 49503 (American Type Culture Collection,
Rockville, MD, USA) was used. Isogenic H. pylori mutants
lacking the cag PAI [31], VacA and virD4 were also studied
together with their parental wild-type strain (26695). Iso-
LY294002 inhibits H. pylori-induced IL-8 expression and pro- duction Figure 6
LY294002 inhibits H. pylori-induced IL-8 expression 
and production. (A) MKN45 cells were preincubated with 
LY294002 (20 μM) for 60 min prior to infection with H. pylori 
(ATCC 49503), harvested at the indicated time points and 
assayed for IL-8 mRNA expression by RT-PCR. Lane M con-
tains markers. (B) LY294002 inhibits H. pylori-induced IL-8 
production. MKN45 cells were preincubated with the indi-
cated concentrations of LY294002 for 60 min prior to infec-
tion with H. pylori (ATCC 49503). For IL-8 protein 
determination, supernatants were collected 24 h after infec-
tion and assessed for IL-8 production by ELISA. Data are 
mean ± SD of three experiments.
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genic null mutants derived from 26695 were constructed
by insertional mutagenesis, using aphA (conferring kan-
amycin resistance). H. pylori strains were plated on blood
agar plates and incubated at 37°C for 2 days under micro-
aerophilic conditions. Using inoculating needles, bacteria
harvested from the plates were suspended in 50 ml of bru-
cella broth containing 5% fetal bovine serum (FBS) and
then cultured in a liquid medium at 37°C for 1 day in a
controlled microaerophilic environment. Bacteria were
harvested from the broth culture by centrifugation and
then resuspended at the concentrations indicated below
in antibiotic-free medium. All procedures were approved
by the appropriate institutional biosafety review commit-
tees and were conducted in compliance with biohazard
guidelines.
Cell culture
The human gastric epithelial cell lines MKN45 and AGS
were maintained in RPMI 1640 containing 10% FBS and
antibiotics. On the day of the experiment, cells were
plated on fresh serum- and antibiotic-free medium and
cocultured with H. pylori at a final concentration of 107
colony forming unit/ml for the times indicated below.
Tissue samples
We examined stomach biopsy specimens from 10 patients
with H. pylori gastritis and three histopathologically-nor-
mal stomach biopsies. We analyzed the phosphorylation
status of Akt at serine 473 and the presence of H. pylori
infection by culture, serological analysis (with anti-H.
pylori IgG antibody), rapid urease test and histological vis-
ualization with Giemsa staining. Patients with H. pylori
gastritis showed polymorphonuclear neutrophil infiltra-
tion in the gastric epithelium in conjunction with bacteria
consistent with H. pylori. All subjects provided informed
consent before obtaining the biopsy samples.
RT-PCR
Total RNA was extracted with Trizol (Invitrogen, Carlsbad,
CA, USA). First-strand cDNA was synthesized using an
RNA PCR kit (Takara Bio, Otsu, Japan). Thereafter, cDNA
was amplified using 25 cycles for IL-8, 35 cycles for p65
and Akt, and 28 cycles for β-actin. The specific primers
used are listed in Table 1. The thermocycling conditions
for the targets were as follows: 94°C for 30 s (for IL-8 and
β-actin) or for 60 s (for p65 and Akt), 60°C for 30 s (for
IL-8 and β-actin) or for 60 s (for p65), or 55°C for 60 s
(for Akt) and 72°C for 90 s (for IL-8 and β-actin) or for 60
s (for p65 and Akt). The PCR products were fractionated
on 2% agarose gels and visualized by ethidium bromide
staining.
Plasmids
The Akt dominant-negative mutant plasmid (pCMV5-
K169A, T308A, S473A-Akt) encodes lysine169 (the ATP-
binding site), threonine 308 and serine 473 (the phos-
phorylation sites) to alanine mutations. Reporter plasmid
κB-LUC is a luciferase expression plasmid controlled by
five tandem repeats of the NF-κB-binding sequences of
the IL-2 receptor (IL-2R) α chain gene.
Transfection and luciferase assay
MKN45 cells were transfected with 1 μg of the appropriate
reporter plasmid and 5 μg of effector plasmid using Lipo-
fectamine (Invitrogen). After 24 h, H. pylori was added at
a ratio of bacteria to cells of 20:1 and incubated for
another 24 h. Luciferase activities were measured using
the dual luciferase assay system (Promega, Madison, WI,
USA) and normalized by the renilla  luciferase activity
from phRL-TK.
Preparation of nuclear extracts and EMSA
Cell pellets were swirled to a loose suspension and treated
with lysis buffer (0.2 ml, containing 10 mM HEPES, pH
7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM
AEBSF and 1 mM DTT) with gentle mixing at 4°C. After
10 min, NP40 was added to a final concentration of 0.8%
and the solution was immediately centrifuged for 5 min at
700 rpm at 4°C. The supernatant was removed carefully
and the nuclei diluted immediately by the addition of
lysis buffer without NP40 (1 ml). The nuclei were then
recovered by centrifugation for 5 min at 700 rpm at 4°C.
Finally, the remaining pellet was suspended on ice in the
following extraction buffer (20 mM HEPES, pH 7.9, 0.4 M
NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 2 mM
AEBSF, 33 μg/ml aprotinin, 10 μg/ml leupeptin, 10 μg/ml
Table 1: Specific primers used in RT-PCR
Primer Sequence Product size (bp)
IL-8 sense 5'-ATGACTTCCAAGCTGGCCGTG-3' 302
antisense 5'-TTATGAATTCTCAGCCCTCTTCAAAAACTTCTC-3'
p65 sense 5'-GCGGCCAAGCTTAAGATCTGCCGAGTAAAC-3' 150
antisense 5'-GCGTGCTCTAGAGAACACAATGGCCACTTGCCG-3'
Akt sense 5'-ATGAGCGACGTGGCTATTGTGAAG-3' 330
antisense 5'-GAGGCCGTCAGCCACAGTCTGGATG-3'
β-actin sense 5'-GTGGGGCGCCCCAGGCACCA-3' 548
antisense 5'-CTCCTTAATGTCACGCACGATTTC-3'BMC Microbiology 2009, 9:36 http://www.biomedcentral.com/1471-2180/9/36
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E-64 and 10 μg/ml pepstatin A) for 30 min to obtain the
nuclear fraction. All fractions were cleared by centrifuga-
tion for 15 min at 15,000 rpm. NF-κB binding activity
with the NF-κB element was examined by EMSA as
described previously [32]. In brief, 5 μg of nuclear extracts
were preincubated in a binding buffer containing 1 μg
poly(dI-dC)·poly(dI-dC) (Amersham Biosciences, Piscat-
away, NJ, USA), followed by the addition of a radiola-
beled oligonucleotide probe containing NF-κB element
from the IL-2R α chain gene (approximately 50,000 cpm).
The radiolabeled oligonucleotide was prepared by filling
in the overhang with the Klenow fragment of DNA
polymerase I in the presence of 32P-dCTP and 32P-dATP.
These mixtures were incubated for 15 min at room tem-
perature. The DNA protein complexes were separated on
a 4% polyacrylamide gel and visualized by autoradiogra-
phy. For competition experiments, the cold oligonucle-
otide probe or competitors were used, and supershift
analysis was performed using antibodies against p50, p65,
c-Rel, p52 or RelB. The probe or competitors used were
prepared by annealing the sense and antisense synthetic
oligonucleotides as follows: for the NF-κB element of the
IL-2R  α chain gene, 5'-GATCCGGCAGGGGAATCTC-
CCTCTC-3'; for the NF-κB element of the CCL20 gene, 5'-
GATCGATCAATGGGGAAAACCCCATGTG-3'; and for the
AP-1 element of the IL-8 gene, 5'-GATCGTGATGACT-
CAGGTT-3'. The above underlined sequences are the NF-
κB and AP-1 binding sites.
Western blot analysis
Cells were lysed in a buffer containing 62.5 mM Tris-HCl,
pH 6.8, 2% sodium dodecyl sulfate, 10% glycerol, 6% 2-
mercaptoethanol and 0.01% bromophenol blue. Equal
amounts of protein (20 μg) were subjected to electro-
phoresis on sodium dodecyl sulfate-polyacrylamide gels,
followed by transfer to a polyvinylidene difluoride mem-
brane and sequential probing with the specific antibodies.
The enhanced chemiluminescence kit (GE Healthcare,
Buckinghamshire, UK) was used for detection. The mem-
branes were stripped in stripping buffer for probing with
a different antibody. Actin served as an internal control in
the Western blot procedure.
Akt kinase assay
A non-radioactivity-based Akt kinase assay kit was pur-
chased from Cell Signaling Technology. After immuno-
precipitation of Akt, the kinase reaction was performed
using the instructions provided by the manufacturer with
glycogen synthase kinase (GSK)-3 fusion protein as an
exogenous substrate. The kinase reaction was analyzed by
immunoblotting, using an anti-phospho-GSK-3 antibody
(serines 21 and 9).
Measurement of IL-8 production
MKN45 cells were cultured in RPMI 1640 supplemented
with 10% FBS in 24-well plates. Subconfluent monolayers
of cells were cocultured with H. pylori for 24 h. The super-
natants were collected and stored at -80°C. IL-8 was meas-
ured by ELISA (BioSource, Camarillo, CA, USA).
RNA interference
The siGENOME mixtures for p65 and Akt were obtained
from Dharmacon (Chicago, IL, USA). All siRNA transfec-
tions were performed using a MicroPorator (Digital Bio,
Seoul, Korea), pulsed once at 1,100 V for 20 ms. The siG-
ENOME non-targeting siRNA served as controls.
Immunohistochemical analysis
Serial sections were deparaffinized in xylene and dehy-
drated using graded ethanol solutions. For better detec-
tion, sections were pretreated with ready-to-use
proteinase K (Dako, Carpentaria, CA, USA) for 10 min at
37°C. This procedure increased the number of antigenic
sites available for binding by the antibody. In the next
step, the tissues were placed in 3% hydrogen peroxide and
absolute methanol for 5 min to reduce endogenous per-
oxidase activity, followed by washing in PBS. Primary
antibody incubations included anti-phospho Akt (serine
473) monoclonal antibody or a control IgG. After wash-
ing with PBS, the sections were covered with EnVision
plus (Dako) for 40 min at 37°C and washed in PBS. Anti-
genic sites bound by the antibody were identified by react-
ing the sections with a mixture of 0.05% 3,3'-
diaminobenzidine tetrahydrochloride in 50 mM Tris-HCl
buffer and 0.01% hydrogen peroxide. Sections were coun-
terstained with methyl green.
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